AU470693B2 - Antithrombogenic process and composition - Google Patents

Antithrombogenic process and composition

Info

Publication number
AU470693B2
AU470693B2 AU34758/71A AU3475871A AU470693B2 AU 470693 B2 AU470693 B2 AU 470693B2 AU 34758/71 A AU34758/71 A AU 34758/71A AU 3475871 A AU3475871 A AU 3475871A AU 470693 B2 AU470693 B2 AU 470693B2
Authority
AU
Australia
Prior art keywords
antithrombogenic
composition
antithrombogenic process
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU34758/71A
Other languages
English (en)
Other versions
AU3475871A (en
Inventor
Ronald Marquis And Roger Leon Vigdahl Norman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Co
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of AU3475871A publication Critical patent/AU3475871A/en
Application granted granted Critical
Publication of AU470693B2 publication Critical patent/AU470693B2/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/45—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by at least one doubly—bound oxygen atom, not being part of a —CHO group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/49—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
    • C07C205/57—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C07C205/59—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton the carbon skeleton being further substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • C07C45/46—Friedel-Crafts reactions
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/84—Ketones containing a keto group bound to a six-membered aromatic ring containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/74—Quinazolines; Hydrogenated quinazolines with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to ring carbon atoms of the hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU34758/71A 1970-10-21 1971-10-19 Antithrombogenic process and composition Expired AU470693B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
USUS82839 1970-10-21
US00082839A US3800039A (en) 1970-10-21 1970-10-21 Antithrombogenic process employing substituted 6,7-dialkoxyquinazolines

Publications (2)

Publication Number Publication Date
AU3475871A AU3475871A (en) 1973-05-03
AU470693B2 true AU470693B2 (en) 1976-03-25

Family

ID=22173777

Family Applications (1)

Application Number Title Priority Date Filing Date
AU34758/71A Expired AU470693B2 (en) 1970-10-21 1971-10-19 Antithrombogenic process and composition

Country Status (9)

Country Link
US (1) US3800039A (enExample)
AU (1) AU470693B2 (enExample)
BE (1) BE774161A (enExample)
DE (1) DE2152521A1 (enExample)
FR (1) FR2111749B1 (enExample)
GB (1) GB1364307A (enExample)
NL (1) NL7114287A (enExample)
PH (1) PH10260A (enExample)
ZA (1) ZA716912B (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1520611A (en) * 1976-06-11 1978-08-09 Wyeth John & Brother Ltd Fused ring indole derivatives
IL89027A (en) * 1988-01-29 1993-01-31 Lilly Co Eli Quinazoline derivatives, process for their preparation and fungicidal, insecticidal and miticidal compositions containing them
US5114939A (en) * 1988-01-29 1992-05-19 Dowelanco Substituted quinolines and cinnolines as fungicides
GT198900008A (es) * 1988-01-29 1990-07-17 Derivados de quinolina, quinazolina y cinolina.
IL89029A (en) * 1988-01-29 1993-01-31 Lilly Co Eli Fungicidal quinoline and cinnoline derivatives, compositions containing them, and fungicidal methods of using them
US5411963A (en) * 1988-01-29 1995-05-02 Dowelanco Quinazoline derivatives
US6645969B1 (en) * 1991-05-10 2003-11-11 Aventis Pharmaceuticals Inc. Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase
US5710158A (en) * 1991-05-10 1998-01-20 Rhone-Poulenc Rorer Pharmaceuticals Inc. Aryl and heteroaryl quinazoline compounds which inhibit EGF and/or PDGF receptor tyrosine kinase
DE69422450T2 (de) * 1993-06-29 2000-06-08 Takeda Chemical Industries, Ltd. Chinoline oder Chinazolin-Derivate und deren Verwendung zur Herstellung eines Medikaments für die Behandlung von Osteoporose
EP0832073B1 (en) * 1995-06-07 2002-01-16 Sugen, Inc. Quinazolines and pharmaceutical compositions
US6706721B1 (en) * 1998-04-29 2004-03-16 Osi Pharmaceuticals, Inc. N-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine mesylate anhydrate and monohydrate
US7087613B2 (en) * 1999-11-11 2006-08-08 Osi Pharmaceuticals, Inc. Treating abnormal cell growth with a stable polymorph of N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochloride
UA74803C2 (uk) 1999-11-11 2006-02-15 Осі Фармасьютікалз, Інк. Стійкий поліморф гідрохлориду n-(3-етинілфеніл)-6,7-біс(2-метоксіетокси)-4-хіназолінаміну, спосіб його одержання (варіанти) та фармацевтичне застосування
AU4903201A (en) 1999-11-30 2001-07-03 Parker Hughes Institute Inhibitors of thrombin induced platelet aggregation
ATE502928T1 (de) 2000-11-01 2011-04-15 Millennium Pharm Inc Stickstoffhaltige heterozyklische verbindungen und verfahren zu deren herstellung
WO2002043735A1 (en) * 2000-11-29 2002-06-06 Parker Hughes Institute Inhibitors of thrombin induced platelet aggregation
JP2002293773A (ja) * 2001-03-30 2002-10-09 Sumika Fine Chemicals Co Ltd キナゾリン誘導体の製造方法
US8246966B2 (en) * 2006-08-07 2012-08-21 University Of Georgia Research Foundation, Inc. Trypanosome microsome system and uses thereof
CA2669531A1 (en) * 2006-11-22 2008-06-05 University Of Georgia Research Foundation, Inc. Tyrosine kinase inhibitors as anti-kinetolastid and anti-apicomplexan agents
NZ585357A (en) * 2007-10-29 2012-02-24 Natco Pharma Ltd Novel 4-(tetrazol-5-yl)-quinazoline derivatives as anti cancer agents
AU2019309942B2 (en) * 2018-07-23 2025-08-14 Ohio State Innovation Foundation Derivatives of papaverine that are effective hypoxic tumor radiosensitizers

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3248292A (en) * 1963-02-06 1966-04-26 Mead Johnson & Co Pharmaceutically active dimethoxyquinazolines
US3517005A (en) * 1967-10-26 1970-06-23 Pfizer & Co C Certain 2- and 4-substituted quinazolines
US3631035A (en) * 1969-04-02 1971-12-28 Pfizer 2-vinyl-1 4-dihydroquinazoline derivatives

Also Published As

Publication number Publication date
US3800039A (en) 1974-03-26
AU3475871A (en) 1973-05-03
GB1364307A (en) 1974-08-21
ZA716912B (en) 1972-06-28
NL7114287A (enExample) 1972-04-25
PH10260A (en) 1976-10-20
FR2111749B1 (enExample) 1975-04-18
DE2152521A1 (de) 1972-04-27
BE774161A (fr) 1972-04-19
FR2111749A1 (enExample) 1972-06-09

Similar Documents

Publication Publication Date Title
AU448307B2 (en) Flavoring compositions and processes
AU3040571A (en) Novel processes and compositions
AU470693B2 (en) Antithrombogenic process and composition
CA966007A (en) Flavoring processes and compositions
CA978956A (en) Oxycyclic flavoring compositions and processes
CA936092A (en) Slimicidal composition and its use
CA960857A (en) Article and method
CA924988A (en) Depurative process and composition
AU3132071A (en) Process and compositions
AU464283B2 (en) Substituted dioxypiperidines and process forthe preparation thereof
AU3204971A (en) Composition of matter and process
AU3040771A (en) Compositions and process
CA850726A (en) Molding composition and method
CA926866A (en) 10-carbamoyl-phenothiazine-3-sulfonamide and production thereof
AU457779B2 (en) Composition and process
CA852227A (en) Compositions and process
AU3481971A (en) Composition and process
CA857843A (en) Metal-disintegrating composition and method
CA836993A (en) Antistatic composition and process
CA842232A (en) Dihydrodecoyinines and processes
CA842233A (en) Deoxydihydrodecoyinines and processes
CA834145A (en) Germaniding and tiniding
CA840444A (en) 1-aminoalkyl-1-phenylindene process and intermediate therefor
AU3263271A (en) Compositions and processes
CA831225A (en) Lapping process and composition